FMC Corp: Form 10-Q for the period ended Mar 31, 2015
Filed with the SEC on May 11, 2015 and accepted by EDGAR at May 11, 2015, 11:25 ET.
Management's discussion and analysis
As filed, 50,740 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.
Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, "expect", “expects”, “should”, “could”, “may”, “will continue to”, "believe", “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of
activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2014 (the “2014 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.
We further caution that the list of risk factors in Item 1A in Part II included in this Form 10-Q may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
APPLICATION OF CRITICAL ACCOUNTING POLICIES
Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2014 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.
The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Critical Accounting Policies” section in our 2014 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.
- Environmental obligations and related recoveries
- Impairment and valuation of long-lived assets
- Pensions and other postretirement benefits
- Income taxes
Subsequent to the acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division (see Note 3 and Note 9 to the condensed consolidated financial statements included within this Form 10-Q for more information) we have reassessed our critical accounting policies. We have concluded that in addition to the four critical accounting policies listed above that our accounting policy over "Revenue recognition and trade receivables" is now critical to our results of operations and financial condition.
Revenue recognition and trade receivables
We recognize revenue when the earnings process is complete, which is generally upon transfer of title. This transfer typically occurs either upon shipment to the customer or upon receipt by the customer. In all cases, we apply the following criteria in recognizing revenue: persuasive evidence of an arrangement exists, delivery has occurred, the selling price is fixed or determinable and collection is reasonably assured. Rebates due to customers are accrued as a reduction of revenue in the same period that the related sales are recorded based on the contract terms.
We periodically enter into prepayment arrangements with customers, primarily in our FMC Agricultural Solutions segment, and receive advance payments for product to be delivered in future periods. These advance payments are recorded as deferred revenue and classified as “Advance payments from customers” on the consolidated balance sheet. Revenue associated with advance payments is recognized as shipments are made and title, ownership and risk of loss pass to the customer.
We record amounts billed for shipping and handling fees as revenue. Costs incurred for shipping and handling are recorded as costs of sales and services. Amounts billed for sales and use taxes, value-added taxes, and certain excise and other specific transactional taxes imposed on revenue-producing transactions are presented on a net basis and excluded from sales in the consolidated income statements. We record a liability until remitted to the respective taxing authority.
Trade receivables consist of amounts owed to us from customer sales and are recorded when revenue is recognized. The allowance for trade receivables represents our best estimate of the probable losses associated with potential customer defaults. In developing our allowance for trade receivables, we utilize a two stage process which includes calculating a general formula to develop an allowance to appropriately address the uncertainty surrounding collection risk of our entire portfolio and specific allowances for customers where the risk of collection has been reasonably identified either due to liquidity constraints or disputes over contractual terms and conditions.
Our method of calculating the general formula consists of estimating the recoverability of trade receivables based on historical experience, current collection trends, and external business factors such as economic factors, including regional bankruptcy rates, and political factors. Our analysis of trade receivable collection risk is performed quarterly, and the allowance is adjusted accordingly.
RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS
See Note 2 to the condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.
OVERVIEW
We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in three distinct business segments: FMC Agricultural Solutions, FMC Health and Nutrition and FMC Lithium. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals – insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. The FMC Health and Nutrition segment focuses on food, pharmaceutical ingredients, nutraceuticals, personal care and similar markets. Our food ingredients are used to enhance texture, color, structure and physical stability. The pharmaceutical additives are used for binding, encapsulation and disintegrant applications. Our FMC Lithium segment produces a wide range of products based on lithium.
First Quarter 2015 Highlights
The following are the more significant developments in our businesses during the three months ended March 31, 2015:
- Revenue of $659.4 million for the three months ended March 31, 2015 decreased $97.5 million or 13 percent versus the same period last year. The decline in revenue was primarily attributable to FMC Agricultural Solutions. A more detailed review of revenues by segment is discussed under the section titled "Results of Operations". On a regional basis, sales in North America remained flat period over period while sales in Asia declined eight percent, sales in Latin America decreased 39 percent and sales in Europe, Middle East and Africa declined 18 percent period over period.
- Our gross margin, excluding acquisition related charges, decreased by approximately $45 million or approximately 15 percent to $250.7 million versus last year's first quarter. Gross margin percent of 38 percent declined from 39 percent. The reduction in gross margin was due to lower volumes in Brazil within FMC Agricultural Solutions. The gross margin decline percent was driven primarily by unfavorable currency movements.
- Selling, general and administrative expenses, excluding acquisition related charges and non-operating pension and postretirement charges decreased by approximately $9 million or nine percent to $101.0 million. The majority of these decreases were experienced in our FMC Agricultural Solutions segment.
- Research and Development expenses of $26.6 million increased $0.8 million or three percent.
- Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $83.8 million decreased by $21.2 million or 20 percent primarily due to lower operating results in FMC Agricultural Solutions. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".
Other Highlights
- On February 3, 2015, we signed a stock and asset purchase agreement ( the "Definitive Agreement") to sell our FMC Alkali Chemicals division ("ACD") to a wholly owned subsidiary of Tronox Limited ("Tronox"). The sale of ACD to Tronox was completed on April 1, 2015 resulting in approximately $1.2 billion in after-tax proceeds.
- On September 8, 2014, we entered into a definitive Share Purchase Agreement with Auriga Industries A/S, a Denmark Aktieselskab and Cheminova A/S, a Denmark Aktieselskab, a wholly owned subsidiary of Auriga. On April 21, 2015, pursuant to the terms and conditions set forth in the Purchase Agreement, we completed the acquisition of 100% of the outstanding equity of Cheminova from Auriga for an aggregate purchase price of 8.5 billion Danish krone or approximately $1.2 billion, excluding net debt to be assumed and hedge related-costs totaling $0.6 billion.
RESULTS OF OPERATIONS
Overview
The following presents a reconciliation of our segment operating profit to the net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).
SEGMENT RESULTS RECONCILIATION
(in Millions)
| 2015 Revenue | Three Months Ended March 31 | 2014 |
|---|---|---|
| FMC Agricultural Solutions | $392.4 | $466.9 |
| FMC Health and Nutrition | 211.0 | 226.2 |
| FMC Lithium | 56.0 | 63.8 |
| Eliminations | — | — |
| Total | $659.4 | $756.9 |
| Income (loss) from continuing operations before income taxes | ||
| FMC Agricultural Solutions | $81.8 | $120.1 |
| FMC Health and Nutrition | 51.0 | 50.9 |
| FMC Lithium | 5.5 | 6.6 |
| Eliminations | — | — |
| Segment operating profit | $138.3 | $177.6 |
| Corporate and other | (15.3) | (17.4) |
| Operating profit before the items listed below | $123.0 | $160.2 |
| Interest expense, net | (14.0) | (11.6) |
| Corporate special (charges) income: | ||
| Restructuring and other (charges) income (1) | (22.3) | (6.7) |
| Non-operating pension and postretirement charges (2) | (6.2) | (4.2) |
| Business separation costs (3) | — | (3.0) |
| Acquisition related charges (4) | (190.7) | (3.1) |
| Provision for income taxes | 49.1 | (34.6) |
| Discontinued operations, net of income taxes | 15.6 | (26.6) |
| Net income attributable to noncontrolling interests | (1.3) | (4.8) |
| Net income (loss) attributable to FMC stockholders | $(46.8) | $65.6 |
(1) See Note 7 for details of restructuring and other charges (income). Amounts for the three months ended March 31, 2015, relate to FMC Agricultural Solutions of $18.3 million, FMC Health and Nutrition of $2.2 million, FMC Lithium of $0.3 million and Corporate of $1.5 million. Amounts for the three months ended March 31, 2014, relate to FMC Health and Nutrition of $4.9 million, FMC Lithium of $0.1 million and Corporate of $1.7 million.
(2) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in the operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. These expenses are included as a component of the line item “Selling, general and administrative expenses” on the condensed consolidated statements of income (loss).
(3) On September 8, 2014, we announced that we would no longer proceed with the planned separation as a result of the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. Business separation costs for the three months ended March 31, 2014 represent charges associated with the planned separation activities through March 31, 2014.
(4) Charges relate to the expensing of the inventory fair value step-up resulting from the application of purchase accounting, legal and professional fees and gains or losses on hedging purchase price associated with the planned or completed acquisitions. Amounts represent the following:
(in Millions)
| Acquisition related charges - Cheminova | Three Months Ended March 31 2015 | 2014 |
|---|---|---|
| Legal and professional fees (1) | $10.6 | $— |
| Loss/(gain) on hedging purchase price (1) | 180.1 | — |
| Acquisition related charges - Epax | ||
| Inventory fair value step-up amortization (2) | — | 3.1 |
| Acquisition/divestiture related charges | $190.7 | $3.1 |
(1) On the condensed consolidated statements of income (loss), these charges are included in “Selling, general and administrative expenses.” For more information on the loss on purchase price hedge see Note 3 to the condensed consolidated financial statements included within this Form 10-Q.
(2) On the condensed consolidated statements of income (loss), these charges are included in “Costs of sales and services.”
The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income attributable to FMC stockholders”. We believe that this measure provides useful information about our operating results to investors and securities analysts. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges, certain tax adjustments from operating results and discontinued operations allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.
ADJUSTED EARNINGS RECONCILIATION
(in Millions)
| 2015 | Three Months Ended March 31 | 2014 |
|---|---|---|
| Net income (loss) attributable to FMC stockholders (GAAP) | $(46.8) | $65.6 |
| Corporate special charges (income), pre-tax | 219.2 | 17.0 |
| Income tax expense (benefit) on Corporate special charges (income) | (80.5) | (5.8) |
| Corporate special charges (income), net of income taxes | $138.7 | $11.2 |
| Discontinued operations, net of income taxes | (15.6) | 28.2 |
| Tax adjustments | 7.5 | — |
| Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP) | $83.8 | $105.0 |
In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.
Segment Results
For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, acquisition related charges, and other income and expense items.
Information about how each of these items relates to our businesses at the segment level and results by segment is discussed in Note 17 of the condensed consolidated financial statements included within this Form 10-Q and in Note 19 of our consolidated financial statements in our 2014 Form 10-K.
FMC Agricultural Solutions
($ in Millions)
| 2015 | Three Months Ended March 31 | 2014 |
|---|---|---|
| Revenue | $392.4 | $466.9 |
| Operating Profit | 81.8 | 120.1 |
Revenue of $392.4 million decreased approximately 16 percent versus the prior year quarter due to sales declines primarily in Latin America. The decrease in revenue period over period was driven by lower volumes of 10 percent, lower average pricing of two percent and unfavorable foreign currency impacts of four percent.
Latin America sales of $79.1 million decreased 44 percent due to market conditions in Brazil and unfavorable currency impacts. North America sales of $218.2 million decreased one percent due to pricing pressure and unfavorable product mix. Europe, Middle East and Africa (EMEA) declined 17 percent to $21.1 million primarily due to high channel inventory. Revenue in Asia of $74.0 million declined eight percent reflecting unfavorable weather conditions in Thailand and Indonesia as well as unfavorable currency impacts.
FMC Agricultural Solutions' operating profit of $81.8 million decreased approximately 32 percent compared to the year-ago quarter, reflecting the sales declines described in the preceding paragraph. Unfavorable foreign currency impacted results by 12 percent as all major currencies experienced significant devaluation against the USD. Selling, general and administrative costs positively impacted results period over period and were approximately $5 million or four percent favorable versus the year ago period due to lower people related costs primarily in Brazil.
Outlook
Global crop protection markets are expected to be down by mid-single digit percent in 2015. The macroeconomic environment remains uncertain, mainly in light of current expectations of currency movements, interest rates, agricultural commodity prices and oil prices. We expect that earnings contributions from the Cheminova acquisition, including early synergy gains, the continued spread of weed resistance in North and Latin America, and market share gains are expected to increase full-year segment earnings by high single-digit to low doubt-digit percent in 2015.
Proforma Financial Results with Cheminova A/S
Beginning in the second quarter of 2015, we will present pro forma combined results for the FMC Agricultural Solutions segment for 2015 and 2014. We believe that reviewing our operating results by combining actual and pro forma results for the FMC Agricultural Solutions segment for 2015 and 2014 is more useful in identifying trends in, or reaching conclusions regarding, the overall operating performance of this segment. Our pro forma segment information will include adjustments as if the Cheminova transaction had occurred on January 1, 2014. Our pro forma data will also be adjusted for the effects of acquisition accounting but will not include adjustments for cost related to integration activities, cost savings or synergies that might be achieved by the combined businesses. Pro forma amounts to be presented will not necessarily be indicative of what our results would have been had we operated Cheminova since January 1, 2014, nor our future results.
Certain Regulatory Issues
A detailed discussion related to regulatory issues impacting FMC Agricultural Solutions can be found in Part II, Item 7 of our 2014 Form 10-K. There have been no material changes related to regulatory issues impacting FMC Agricultural Solutions from the information reported in our 2014 10-K.
FMC Health and Nutrition
($ in Millions)
| 2015 | Three Months Ended March 31 | 2014 |
|---|---|---|
| Revenue | $211.0 | $226.2 |
| Operating Profit | 51.0 | 50.9 |
Revenue was $211.0 million, a decrease of approximately seven percent versus the prior-year quarter. Unfavorable foreign currency impacts, primarily a weaker Euro, decreased revenue by approximately five percent and lower volumes, principally in alginates impacted revenue by approximately two percent.
Segment operating profit of $51.0 million remained flat versus the year ago quarter driven by the revenue decline discussed in the preceding paragraph offset by improved product mix.
Outlook
In 2015, we expect full-year segment operating profit to increase by mid-single digit percent. Earnings growth is expected to come from continued demand for pharmaceutical excipients and benefits from ongoing operational improvement and restructuring programs.
FMC Lithium
($ in Millions)
| 2015 | Three Months Ended March 31 | 2014 |
|---|---|---|
| Revenue | $56.0 | $63.8 |
| Operating Profit | 5.5 | 6.6 |
Revenue of $56.0 million decreased by approximately 12 percent versus the prior-year quarter. Revenue decreases were driven by lower volumes of butyllithium, which represented approximately 13 percent of the revenue reduction. Unfavorable foreign currency impacts decreased revenue by two percent while pricing was favorable by three percent.
Segment operating profit of $5.5 million decreased approximately 17 percent versus the year ago quarter as improved operations were offset by the increasing cost environment in Argentina.
Outlook
In 2015, we expect full-year revenue to be relatively flat in spite of continuing currency headwinds. We expect segment operating profit to be within the range of $15 to $25 million.
Other Results of Operations
Corporate and other
Corporate and other expenses are included as a component of the line item “Selling, general and administrative expenses” except for LIFO related charges that are included as a component of "Cost of sales and services" on the condensed consolidated statements of income (loss).
Corporate and other expenses of $15.3 million in the first quarter of 2015 decreased by $2.1 million from $17.4 million in the same period in 2014. The decrease is partially driven by a decrease in employees' incentive accruals of approximately $2.5 million driven primarily by the outlook of our segments as noted above.
Interest expense, net
Three Months Ended March 31, 2015 vs. 2014
Interest expense, net for the first quarter of 2015 was $14.0 million as compared to the first quarter of 2014 of $11.6 million. The increase was primarily due to an increase in short-term foreign debt outstanding and an increase in interest rates for our commercial paper program for the three months ended March 31, 2015 compared to 2014.
Corporate special (charges) income
Three Months Ended March 31, 2015 vs. 2014
Restructuring and other charges (income)
(in Millions)
| Three Months Ended March 31 2015 | 2014 | |
|---|---|---|
| Restructuring charges and asset disposals | $5.4 | $5.3 |
| Other charges (income), net | 16.9 | 1.4 |
| Total restructuring and other charges | $22.3 | $6.7 |
Restructuring and asset disposal charges in 2015 of $5.4 million were primarily associated with the announced Health and Nutrition restructuring. Other charges (income) net in 2015 of $16.9 million were primarily comprised of a $15.0 million payment for the acquisition of all global rights to a pre-development novel, proprietary broadleaf herbicide. This acquisition is considered as in-process research and development and in accordance with GAAP, the amounts paid were expensed as incurred since they were acquired outside of a business combination.
Restructuring and asset disposal charges in 2014 of $5.3 million were primarily associated with the Health and Nutrition restructuring. Other charges (income) net in 2014 of $1.4 million were primarily related to corporate environmental charges.
The liabilities associated with the restructuring charges listed above are also included within Note 7 to the condensed consolidated financial statements included in this Form 10-Q. We believe the restructuring plans implemented are on schedule and the benefits and savings either have been or will be achieved.
Non-operating pension and postretirement charges
The charge for the three months ended March 31, 2015 was $6.2 million compared to $4.2 million for the three months ended March 31, 2014. The increase in charges was primarily the result of higher amortization impacts of actuarial losses, see Note 13 to the condensed consolidated financial statements included in this Form 10-Q for more information. These expenses are included as a component of the line item "Selling, general and administrative expenses" on the condensed consolidated statements of income (loss).
Business separation costs
On September 8, 2014, we announced that we would no longer proceed with the planned separation as a result of the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. Business separation costs for the three months ended March 31, 2014 represent charges associated with the planned separation activities through March 31, 2014.
Acquisition related charges
A detailed description of the acquisition related charges is included in Note 17 to the condensed consolidated financial statements included within this Form 10-Q. These expenses are included as a component of the line item "Selling, general and administrative expenses" on the condensed consolidated statements of income (loss).
Provision for income taxes
A significant amount of our earnings is generated by our foreign subsidiaries (e.g. Ireland and Hong Kong), which tax earnings at lower rates than the United States federal statutory rate. Our future effective tax rates may be materially impacted by numerous items including: a future change in the composition of earnings from foreign and domestic tax jurisdictions, as earnings in foreign jurisdictions are typically taxed at more favorable rates than the United States federal statutory rate; accounting for uncertain tax positions; business combinations; closure of statute of limitations or settlement of tax audits; changes in valuation allowance and changes in tax law; and the potential decision to repatriate certain future foreign earnings.
Income tax benefit was $49.1 million resulting in an effective tax rate of 44.6 percent compared to a provision of $34.6 million resulting in an effective tax rate of 26.3 percent for the three months ended March 31, 2015 and 2014, respectively. Excluding discrete items, the effective rate is 26.4 percent compared to 26.8 percent for the three months ended March 31, 2015 and 2014, respectively. A more detailed description of the change and drivers to the change in the effective tax rate is included in Note 14 to the condensed consolidated financial statements included within this Form 10-Q.
Discontinued operations, net of income taxes
Our discontinued operations represent our discontinued FMC Alkali Chemicals and FMC Peroxygens division results as well as adjustments to retained liabilities from other previously discontinued operations. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.
Three Months Ended March 31, 2015 vs. 2014
Discontinued operations, net of income taxes represented a gain of $15.6 million for the three months ended March 31, 2015, compared to a loss of $26.6 million for the three months ended March 31, 2014. The change was driven by the completed divestiture of our FMC Peroxygens business in the three months ended March 31, 2014 which resulted in an after tax loss of $40.0 million in 2014. For more information on our discontinued operations, net of income taxes, see Note 9 to the condensed consolidated financial statements included in this Form 10-Q.
Net income (loss) attributable to FMC stockholders
Three Months Ended March 31, 2015 vs. 2014
Net loss attributable to FMC stockholders decreased to $46.8 million from income of $65.6 million. The decrease was primarily due to acquisition related charges, primarily the purchase price hedge, associated with the Cheminova A/S acquisition recorded during the current quarter, and lower segment operating profit in FMC Agricultural Solutions.
LIQUIDITY AND CAPITAL RESOURCES
Cash and cash equivalents at March 31, 2015 and December 31, 2014, were $105.2 million and $109.5 million, respectively. Of the cash and cash equivalents balance at March 31, 2015, $79.9 million were held by our foreign subsidiaries. Our intent is to reinvest permanently the earnings of our foreign subsidiaries and therefore we have not recorded taxes that would be payable if we repatriated these earnings.
At March 31, 2015, we had total debt of $2,058.2 million as compared to $1,678.6 million at December 31, 2014. Total debt included $1,150.9 million and $1,153.4 million of long-term debt (excluding current portions of $1.7 million and $2.0 million) at March 31, 2015 and December 31, 2014, respectively. Short-term debt, which consists primarily of borrowings under our commercial paper program, increased from $523.2 million at December 31, 2014 to $905.6 million at March 31, 2015. Our commercial paper program allows us to borrow at rates generally more favorable than those available under our credit facility. We have used proceeds from the commercial paper program for general corporate purposes. At March 31, 2015, the average effective interest rate on these borrowings was 0.62%.
The increase in short term debt is primarily timing related to the settlement of the Cheminova A/S purchase price hedge totaling $273.8 million in the first quarter of 2015 in advance of the closing of the acquisition in April of 2015. Short-term borrowings under the commercial paper program were used to fund the settlement of these hedges. For more detail on the hedges and related accounting treatment refer to Note 3 to the condensed consolidated financial statements included within this Form 10-Q.
Statement of Cash Flows
Cash provided (required) by operating activities was $(304.9) million and $(106.0) million for the three months ended March 31, 2015 and 2014, respectively.
The table below presents the components of net cash provided (required) by operating activities.
(in Millions)
| 2015 | Three Months Ended March 31 | 2014 |
|---|---|---|
| Income (loss) from continuing operations before equity in (earnings) loss of affiliates, interest income and expense and income taxes | $(96.1) | $142.9 |
| Significant non-cash expenses (1) | 39.2 | 36.2 |
| Operating income before non-cash expenses (Non-GAAP) | $(56.9) | $179.1 |
| Change in trade receivables (2) | 52.5 | (80.3) |
| Change in inventories (3) | (50.0) | (9.5) |
| Change in accounts payable (4) | (35.6) | (77.7) |
| Change in accrued rebates (5) | 87.6 | 87.4 |
| Change in advance payments from customers (6) | (165.9) | (148.4) |
| Change in all other operating assets and liabilities (7) | (72.4) | 10.6 |
| Restructuring and other spending (8) | (3.0) | (1.9) |
| Environmental spending, continuing, net of recoveries (9) | (3.0) | (1.6) |
| Pension and other postretirement benefit contributions (10) | (27.4) | (23.8) |
| Cash basis operating income (Non-GAAP) | $(274.1) | $(66.1) |
| Interest payments | (18.0) | (11.2) |
| Tax payments | (11.1) | (25.3) |
| Excess tax benefits from share-based compensation | (1.7) | (3.4) |
| Cash provided (required) by operating activities | $(304.9) | $(106.0) |
(1) Represents the sum of depreciation, amortization, non-cash asset write downs, share-based compensation, and pension charges.
(2) The decrease in trade receivables in the first quarter of 2015 was driven by reduced revenue in Agricultural Solutions primarily in Brazil. The first quarter of 2014 was primarily driven by collection timing in that period. Collection timing is more pronounced in our FMC Agricultural Solutions business where sales, particularly in Brazil, have terms significantly longer than the rest of our businesses. Additionally, timing of collection is impacted as amounts for both periods include carry-over balances remaining to be collected in Latin America, where collection periods are measured in months rather than weeks.
(3) Inventory levels increased in the first quarter of 2015 due to lower than expected first quarter sales as well as inventory build to satisfy expected demand in the current growing season in our FMC Agricultural Solutions segment. Inventory levels remained fairly constant during the first quarter of 2014 as compared to that prior year end.
(4) The decrease in accounts payable balances during the first quarter of 2015 is primarily due to timing of payments. The higher use of cash in our accounts payable during the first quarter of 2014 was driven by a Q4 2013 inventory build primarily in our FMC Agricultural Solutions segment to satisfy projected 2014 demand, which was paid during the first quarter of 2014.
(5) These rebates are associated with our FMC Agricultural Solutions segment, primarily in North America and Brazil and generally settle in the fourth quarter of each year.
(6) The advance payments from customers represent advances from our FMC Agricultural Solutions segment customers. During the past two years we received substantial increases in advance payments from customers at the end of the preceding years for the subsequent years planting season.
(7) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities. The first quarter 2015 was primarily impacted by the payments of $273.8 million for the Cheminova A/S purchase price hedges.
(8) See Note 7 in the condensed consolidated financial statements included in this Form 10-Q for further details.
(9) Included in our income presented for the three months ended March 31, 2015 and March 31, 2014 are environmental charges for environmental remediation at our operating sites of $1.9 million and $1.4 million, respectively. The amounts in 2015 will be spent in periods beyond first quarter 2015. The amounts in this row represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries.
(10) Amounts include voluntary contributions to our U.S. defined benefit plan of $25.0 million and $17.0 million, respectively.
Cash provided (required) by operating activities of discontinued operations was $7.7 million and $9.2 million for the three months ended March 31, 2015 and 2014, respectively.
The reduction of cash provided by operating activities of discontinued operations in 2015 is due primarily to a decline in the operating results of our discontinued FMC Alkali business in 2015 compared to 2014. The decline in results is driven by $11.3 million of divestiture related charges in 2015. Partially offset this reduction of cash provided by our discontinued FMC Alkali business was reduced spending on Environmental remediation in 2015 as compared to 2014.
Cash provided (required) by investing activities of continuing operations was $(54.2) million and $(64.4) million for the three months ended March 31, 2015 and 2014, respectively.
The decrease in spending during the three months ended March 31, 2015, as compared to the same period in 2014 was primarily due to lower capital expenditures in our FMC Health and Nutrition segment.
Cash provided (required) by investing activities of discontinued operations was $(15.6) million and $188.0 million for the three months ended March 31, 2015 and 2014, respectively.
Cash provided by investing activities of discontinued operations in 2014 is directly associated with the sale of our FMC Peroxygens business which was completed on February 28, 2014. For more information see Note 9 to the condensed consolidated financial statements included in this Form 10-Q.
Cash provided (required) by financing activities was $364.8 million and $(56.7) million for the three months ended March 31, 2015 and 2014, respectively.
The change period over period in financing activities is primarily due to increased borrowings primarily to fund the settlement of the purchase price hedges for the Cheminova A/S acquisition. In 2015 borrowings were approximately $383 million compared to repayments in 2014 of $40 million.
Other potential liquidity needs
Our cash needs outside of the Cheminova acquisition and related integration expenses for 2015 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At March 31, 2015, our remaining borrowing capacity under our credit facility was $534.8 million (which includes borrowings under our commercial paper program).
As discussed throughout this 10-Q, we closed on the Cheminova acquisition in April of 2015 as well as completed the sale of our FMC Alkali Chemicals division in that same month. The proceeds from the FMC Alkali Chemicals sale as well as borrowings under our term loan facility were used to finance the acquisition. Please see Note 8 to the condensed consolidated financial statements included within this Form 10-Q for more detail on the term loan.
Projected 2015 capital expenditures as well as expenditures related to contract manufacturers are expected to be lower than 2014 levels. This includes expected spending for Cheminova subsequent to the acquisition.
Projected 2015 spending includes approximately $60 million of net environmental remediation spending. This spending does not include expected spending on capital projects relating to environmental control facilities or expected spending for environmental compliance costs, which we will include as a component of costs of sales and services to the condensed consolidated statements of income (loss) since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls over the foregoing projections.
In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan, we have made voluntary contributions through March 31, 2015 and March 31, 2014 of $25.0 million and $17.0 million, respectively. We expect to make approximately $65 million in voluntary cash contributions to our U.S. defined benefit pension plan during 2015. These contributions are in excess of the minimum requirements. We made voluntary contributions of $50 million in 2014. We do not believe that these projected contributions will have a significant negative impact on our current and future liquidity needs. However, any volatility of interest rates or negative equity returns may require greater contributions to the U.S. Plan in the future.
For the three months ended March 31, 2015 and 2014, we paid $20.1 million and $18.0 million, respectively, in dividends declared in previous periods. On April 16, 2015, we paid dividends totaling $22.1 million to our shareholders of record as of March 31, 2015. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of March 31, 2015.
During the three months ended March 31, 2015, we did not repurchase any shares under the publicly announced repurchase program. At March 31, 2015, $250.0 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.
Commitments and Contingencies
See Note 16 to the condensed consolidated financial statements included in this Form 10-Q.
Contractual Commitments
Information related to our contractual commitments at December 31, 2014 can be found in a table included within Part II, Item 7 of our 2014 Form 10-K. There have been no significant changes to our contractual commitments during the three months ended March 31, 2015.
Climate Change
A detailed discussion related to climate change can be found in Part II, Item 7 of our 2014 Form 10-K. Our former FMC Alkali Chemicals division mined and refined trona ore into soda ash, and this activity constituted most of FMC’s greenhouse gas emissions globally. The sale of our Alkali Chemicals Division was completed on April 1, 2015 as discussed further in Note 9 to the condensed consolidated financial statements included within this Form 10-Q. As a result, we no longer have the level of greenhouse gas emissions that were previously driven by this business.
On April 21, 2015, we completed the acquisition of Cheminova A/S as discussed further in Note 3 to the condensed consolidated financial statements included within this Form 10-Q. Cheminova A/S has foreign operations with multiple plants, which may be subject to national or local energy management or climate change regulation. Therefore, we will evaluate any such regulations as these facilities and will routinely assess the consequences of potential future climate change on our operations.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.
Fair-Value Measurements
See Note 15 to the condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.
DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS
Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.
The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.
At March 31, 2015, our financial instrument position was a net asset of $20.1 million compared to a net liability of $92.5 million at December 31, 2014. The change in the net financial instrument position was primarily due to the settlement of outstanding hedges for the purchase price of Cheminova A/S, see Note 3 to the condensed consolidated financial statement included within this Form 10-Q for more information.
Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.
Commodity Price Risk
Energy costs are diversified among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at March 31, 2015 and December 31, 2014, with all other variables (including interest rates) held constant.
(in Millions)
| Net Asset / (Liability) Position on Consolidated Balance Sheets | Hedged energy exposure vs. Energy market pricing 10% Increase | 10% Decrease | |
|---|---|---|---|
| Net asset/(liability) position at March 31, 2015 | $(2.8) | $(2.2) | $(3.4) |
| Net asset/(liability) position at December 31, 2014 | $(7.3) | $(5.3) | $(9.4) |
Our FMC Agricultural Solutions segment enters into contracts with certain customers in Brazil to exchange our products for future physical delivery of soybeans. To mitigate the price risk associated with these barter contracts, we enter into offsetting derivatives to hedge our exposure. As of March 31, 2015 and December 31, 2014 our net financial instrument position was immaterial.
Foreign Currency Exchange Rate Risk
The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan and the U.S. dollar versus the Brazilian real. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.
To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at March 31, 2015 and December 31, 2014, with all other variables (including interest rates) held constant.
(in Millions)
| Net Asset / (Liability) Position on Consolidated Balance Sheets | Hedged Currency vs. Functional Currency 10% Strengthening (1) | 10% Weakening (1) | |
|---|---|---|---|
| Net asset/(liability) position at March 31, 2015 | $22.9 | $185.8 | $(140.9) |
| Net asset/(liability) position at December 31, 2014 | $(85.2) | $91.3 | $(261.0) |
(1) Impacted by the purchase price hedges for the Cheminova A/S acquisition. Total notional value of outstanding hedges is approximately $2.6 billion.
Interest Rate Risk
One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of March 31, 2015 and December 31, 2014, we had no interest rate swap agreements.
Our debt portfolio, at March 31, 2015, is composed of 57 percent fixed-rate debt and 43 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our Credit Facility, commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.
Based on the variable-rate debt in our debt portfolio at March 31, 2015, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $2.2 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $1.4 million for the three months of March 31, 2015.
Market risk
As filed, 207 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Controls and procedures
As filed, 3,484 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2015, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended March 31, 2015, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Shareholders
FMC Corporation:
We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of March 31, 2015, the related condensed consolidated statements of income (loss) and comprehensive income (loss), for the three-month periods ended March 31, 2015 and 2014, and the related condensed consolidated statements of cash flows for the three-month periods ended March 31, 2015 and 2014. These condensed consolidated financial statements are the responsibility of the Company’s management.
We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.
We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2014, and the related consolidated statements of income, comprehensive income, cash flows, and changes in equity for the year then ended (not presented herein); and in our report dated February 27, 2015, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2014, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.
/s/ KPMG LLP
Philadelphia, Pennsylvania
May 11, 2015
Risk factors
As filed, 21,140 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Subsequent to the acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division (see Note 3 and Note 9 to the condensed consolidated financial statements included within this Form 10-Q for more information) we have reassessed our risk factors. Below lists our risk factors updated for these events.
Among the factors that could have an impact on our ability to achieve operating results and meet our other goals are:
Industry Risks:
Pricing and volumes in our markets are sensitive to a number of industry specific and global issues and events including:
- Capacity utilization - Our businesses are sensitive to industry capacity utilization. As a result, pricing tends to fluctuate when capacity utilization changes occur within our industry.
- Competition - All of our segments face competition, which could affect our ability to maintain or raise prices, successfully enter certain markets or retain our market position. Our FMC Agricultural Solutions, competition includes not only generic suppliers of the same pesticidal active ingredient, but also alternative proprietary pesticide chemistries, crop protection technologies that are bred into or applied onto seeds, and intellectual property regarding production or use of pesticides. Increased generic presence in agricultural chemical markets has been driven by the number of significant product patents and product data protections that have expired in the last decade, and this trend is expected to continue.
- Changes in our customer base - Our customer base has the potential to change, especially when long-term supply contracts are renegotiated. Our FMC Minerals and FMC Health and Nutrition businesses are most sensitive to this risk.
- Climatic conditions - Our FMC Agricultural Solutions markets are affected by climatic conditions, which could adversely impact crop pricing and pest infestations. Adverse weather conditions can impact our ability to extract lithium efficiently from our lithium reserves in Argentina. Natural disasters can impact production at our facilities in various parts of the world. The nature of these events makes them difficult to predict.
- Changing regulatory environment - Changes in the regulatory environment, particularly in the United States, Brazil, China and the European Union, could adversely impact our ability to continue producing and/or selling certain products in our domestic and foreign markets or could increase the cost of doing so. Our FMC Agricultural Solutions business is most sensitive to this general regulatory risk given the need to obtain and maintain pesticide registrations in every country in which we sell our products. Compliance with changing laws and regulations may involve significant costs or capital expenditures or require changes in business practice that could result in reduced profitability. In the European Union, the regulatory risk specifically includes chemicals regulation known as REACH (Registration, Evaluation, and Authorization of Chemicals), which affects each of our business segments to varying degrees. The fundamental principle behind the REACH regulation is that manufacturers must verify that their chemicals can be marketed safely through a special registration system.
- Geographic concentration - Although we have operations in most regions throughout the globe, the majority of our FMC Agricultural Solutions sales outside the United States have principally been to customers in Brazil, Argentina and Mexico. With the acquisition of Cheminova, we will expand the reach of international sales to include Europe and key Asian countries. Accordingly, developments in those parts of the world generally have a more significant effect on our operations than developments in other places. Our operations outside the United States are subject to special risks and restrictions, including: fluctuations in currency values; exchange control regulations; changes in local political or economic conditions; governmental pricing directives; import and trade restrictions; import or export licensing requirements and trade policy; restrictions on the ability to repatriate funds; and other potentially detrimental domestic and foreign governmental practices or policies affecting U.S. companies doing business abroad.
- Food and pharmaceutical regulation - Some of our manufacturing processes and facilities, as well as some of our customers, are subjected to regulation by the U.S. Food and Drug Administration (FDA) or similar foreign agencies. Regulatory requirements of the FDA are complex, and any failure to comply with them including as a result of contamination due to acts of sabotage could subject us and/or our customers to fines, injunctions, civil penalties, lawsuits, recall or seizure of products, total or partial suspension of production, denial of government approvals, withdrawal of marketing approvals and criminal prosecution. Any of these actions could adversely impact our net sales, undermine goodwill established with our customers, damage commercial prospects for our products and materially adversely affect our results of operations.
- Climate change regulation - Changes in the regulation of greenhouse gases, depending on their nature and scope, could subject our manufacturing operations, particularly certain FMC Minerals' operations in the United States, to significant additional costs or limits on operations.
- Fluctuations in commodity prices - Our operating results could be significantly affected by the cost of commodities such as raw materials and energy, including natural gas. We may not be able to raise prices or improve productivity sufficiently to offset future increases in commodity pricing. Accordingly, increases in commodity prices may negatively affect our financial results. Where practical, we use hedging strategies to address material commodity price risks, where hedge strategies are available on reasonable terms. We also use raw material supply agreements that contain terms designed to mitigate the risk of short-term changes in commodity prices. However, we are unable to avoid the risk of medium- and long-term increases. Additionally, fluctuations in commodity prices could negatively impact our customers' ability to sell their product at previously forecasted prices resulting in reduced customer liquidity. Inadequate customer liquidity could affect our customers’ abilities to pay for our products and, therefore, affect existing and future sales or our ability to collect on customer receivables.
- Supply arrangements - Certain raw materials are critical to our production process. While we have made supply arrangements to meet planned operating requirements, an inability to obtain the critical raw materials or execute under the contract manufacturing arrangements would adversely impact our ability to produce certain products. We increasingly source critical intermediates and finished products from a number of suppliers. An inability to obtain these products or execute under the contract sourcing arrangements would adversely impact our ability to sell products. In FMC Minerals geological conditions can affect production of raw materials.
- Economic and political change - Our business could be adversely affected by economic and political changes in the markets where we compete including: inflation rates, recessions, trade restrictions, foreign ownership restrictions and economic embargoes imposed by the United States or any of the foreign countries in which we do business; changes in laws, taxation, and regulations and the interpretation and application of these laws, taxes, and regulations; restrictions imposed by foreign governments through exchange controls or taxation policy; nationalization or expropriation of property, undeveloped property rights, and legal systems or political instability; other governmental actions; and other external factors over which we have no control. Economic and political conditions within foreign jurisdictions or strained relations between countries can cause fluctuations in demand, price volatility, supply disruptions, or loss of property. In Argentina, continued inflation and tightening of foreign exchange controls along with deteriorating economic and financial conditions could adversely affect our business.
Operational Risks:
- Market access risk - Our results may be affected by changes in distribution channels, which could impact our ability to access the market. In certain FMC Agricultural Solutions segments, we access the market through joint ventures in which we do not have majority control. Where we do not have a strong product portfolio or market access relationships, we may be vulnerable to changes in the distribution model or influence of competitors with stronger product portfolios.
- Business disruptions - Although historically, we have engaged in contract manufacturing and has not owned and operated its own manufacturing facilities, Cheminova owns and operates large-scale manufacturing facilities in Denmark and India. This will present us with new material operating risks that we have not historically faced. After the Cheminova acquisition is completed, our operating results will be dependent on the continued operation of its various production facilities and the ability to manufacture products on schedule. Interruptions at these facilities may materially reduce the productivity and profitability of a particular manufacturing facility, or our business as a whole, during and after the period of such operational difficulties. Although we take precautions to enhance the safety of our operations and minimize the risk of disruptions, our operations are subject to hazards inherent in chemical manufacturing and the related storage and transportation of raw materials, products and wastes. These potential hazards include, explosions, fires, severe weather and natural disasters, mechanical failure, unscheduled downtimes, supplier disruptions, labor shortages or other labor difficulties, information technology systems outages, disruption in our supply chain or manufacturing and distribution operations, transportation interruptions, chemical spills, discharges or releases of toxic or hazardous substances or gases, shipment of incorrect or off-specification product to customers, storage tank leaks, other environmental risks, or other sudden disruption in business operations beyond our control as a result of events such as acts of sabotage, terrorism or war, civil or political unrest, natural disasters, pandemic situations and large scale power outages. Some of these hazards may cause severe damage to or destruction of property and equipment or personal injury and loss of life and may result in suspension of operations or the shutdown of affected facilities.
- Our manufacturing operations and those of our key contract manufacturers inherently entail hazards that require continuous oversight and control, such as leaks, ruptures, fire, explosions, chemical spills, discharges or releases of toxic or hazardous substances or gases, other environmental risks, mechanical failure or other hazards beyond our control such as acts of sabotage, terrorism or war, civil or political unrest, natural disasters, pandemic situations, large scale power outages or vehicle accidents. If operational risks materialize, they could result in loss of life, damage to the environment, or loss of production, all of which could negatively impact our ongoing operations, reputation, financial results, and cash flow.
- Information technology security risks - As with all Enterprise Information systems, our information technology systems could be penetrated by outside parties intent on extracting information, corrupting information, or disrupting business processes. Our systems have in the past been, and likely will in the future be, subject to unauthorized access attempts. Unauthorized access could disrupt our business operations and could result in failures or interruptions in our computer systems and in the loss of assets and could have a material adverse effect on our business, financial condition or results of operations. In addition, breaches of our security measures or the accidental loss, inadvertent disclosure, or unapproved dissemination of proprietary information or sensitive or confidential information about us, our employees, our vendors, or our customers, could result in litigation and potential liability for us, damage our reputation, or otherwise harm our business, financial condition, or results of operations.
- Capital-intensive business - With our impending acquisition of Cheminova, our business will be more capital intensive, than it has been historically. We rely on cash generated from operations and external financing to fund our growth and ongoing capital needs. Limitations on access to external financing could adversely affect our operating results. Moreover, interest payments, dividends and the expansion of our business or other business opportunities may require significant amounts of capital. We believe that our cash from operations and available borrowings under our revolving credit facility will be sufficient to meet these needs in the foreseeable future. However, if we need external financing, our access to credit markets and pricing of our capital will be dependent upon maintaining sufficient credit ratings from credit rating agencies and the state of the capital markets generally. There can be no assurances that we would be able to obtain equity or debt financing on terms we deem acceptable, and it is possible that the cost of any financings could increase significantly, thereby increasing our expenses and decreasing our net income. If we are unable to generate sufficient cash flow or raise adequate external financing, including as a result of significant disruptions in the global credit markets, we could be forced to restrict our operations and growth opportunities, which could adversely affect our operating results.
We may use our $1.5 billion revolving credit facility to meet our cash needs, to the extent available. As of March 31, 2015, we had unused and available credit capacity of $534.8 million. In the event of a default under our credit facility or any of our senior notes, we could be required to immediately repay all outstanding borrowings and make cash deposits as collateral for all obligations the facility supports, which we may not be able to do. Any default under any of our credit arrangements could cause a default under many of our other credit agreements and debt instruments. Without waivers from lenders party to those agreements, any such default could have a material adverse effect on our ability to continue to operate.
- Litigation and environmental risks - Current reserves relating to our ongoing litigation and environmental liabilities may ultimately prove to be inadequate.
- Hazardous materials - We manufacture and transport certain materials that are inherently hazardous due to their toxic or volatile nature. While we take precautions to handle and transport these materials in a safe manner, if they are mishandled or released into the environment, they could cause property damage or personal injury claims against us.
- Environmental Compliance - We are subject to extensive federal, state, local, and foreign environmental and safety laws. regulations, directives, rules and ordinances concerning, among other things, emissions in the air, discharges to land and water, and the generation, handling, treatment, disposal and remediation of hazardous waste and other materials. We may face liability arising out of the normal course of business, including alleged personal injury or property damage due to exposure to chemicals or other hazardous substances at our current or former facilities or chemicals that we manufacture, handle or own. We take our environmental responsibilities very seriously, but there is a risk of environmental impact inherent in its manufacturing operations and transportation of chemicals. Any substantial liability for environmental damage could have a material adverse effect on our financial condition, results of operations and cash flows.
- Inability to attract and retain key employees - The inability to recruit and retain key personnel or the unexpected loss of key personnel may adversely affect our operations. In addition, our future success depends in part on our ability to identify and develop talent to succeed senior management.
Technology Risks:
- Our ability to compete successfully depends in part upon our ability to maintain a superior technological capability and to continue to identify, develop and commercialize new and innovative, high value-added products for existing and future customers.
- Failure to continue to make process improvements to reduce costs could impede our competitive position.
Portfolio Management Risks:
- We continuously review our portfolio which includes the evaluation of potential business acquisitions that may strategically fit our business and strategic growth initiatives. If we are unable to successfully integrate and develop our acquired businesses, we could fail to achieve anticipated synergies which would include expected cost savings and revenue growth. Failure to achieve these anticipated synergies, could materially and adversely affect our financial results. In addition to strategic acquisitions we evaluate the diversity of our diverse portfolio in light of our objectives and alignment
with its growth strategy. As part of this evaluation we may not be successful in separating underperforming or non-strategic assets and gains or losses on the divestiture of, or lost operating income from, such assets may affect the company’s earnings. Moreover, we may incur asset impairment charges related to acquisitions or divestitures that reduce its earnings.
In particular, inability to successfully integrate and develop Cheminova as planned could result in our inability to achieve the synergies we have projected and could thereby cause our future results of operations to be materially and adversely worse than expected. Part of the synergies we expect to generate is the improvement of the cost-efficiency of Cheminova’s business operations. Another is to reduce the mix of Cheminova’s sales from generic, lower margin products to more differentiated and higher margin products. Yet another will be the favorable rationalization of the different distribution channels used by FMC and Cheminova in overlapping European markets. There can be no assurances that we will be successful in achieving these planned synergies.
Financial Risks:
- Deterioration in the global economy and worldwide credit and foreign exchange markets could adversely affect our business. A worsening of global or regional economic conditions or financial markets could adversely affect our customers' ability to meet the terms of sale or our suppliers' ability to perform all their commitments to us. A slowdown in economic growth in our international markets, particularly Latin American regions, or a deterioration of credit or foreign exchange markets could adversely affect customers, suppliers and our overall business there. Customers in weakened economies may be unable to purchase our products, or it could become more expensive for them to purchase imported products in their local currency, or sell their commodity at prevailing international prices, and we may be unable to collect receivables from such customers.
- We are an international company and face foreign exchange rate risks in the normal course of our business. We are particularly sensitive to the euro, the Brazilian real and the Chinese yuan. To a lesser extent, we are sensitive to the Mexican peso, the Argentine peso, the British pound sterling and several Asian currencies, including the Japanese yen. Our acquisition of Cheminova has significantly expanded our operations and sales in foreign countries and correspondingly increase our exposure to foreign exchange risks.
- Our future effective tax rates may be materially impacted by numerous items including: a future change in the composition of earnings from foreign and domestic tax jurisdictions, as earnings in foreign jurisdictions are typically taxed at more favorable rates than the United States federal statutory rate; accounting for uncertain tax positions; business combinations; closure of statute of limitations or settlement of tax audits; changes in valuation allowance and changes in tax law; and the potential decision to repatriate certain future foreign earnings.
- We have significant investments in long-lived assets and continually review the carrying value of these assets for recoverability in light of changing market conditions and alternative product sourcing opportunities.
- Obligations related to our pension and postretirement plans reflect certain assumptions. To the extent our plans' actual experience differs from these assumptions, our costs and funding obligations could increase or decrease significantly.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-01-01 to 2015-03-31 | $659.4m | us-gaap:Revenues |
| Cost of revenue | 3 months2015-01-01 to 2015-03-31 | $408.7m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2015-01-01 to 2015-03-31 | $250.7m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2015-01-01 to 2015-03-31 | $297.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2015-01-01 to 2015-03-31 | −$96.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2015-01-01 to 2015-03-31 | −$49.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-01-01 to 2015-03-31 | −$46.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-01-01 to 2015-03-31 | −$0.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-01-01 to 2015-03-31 | −$0.35 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-01-01 to 2015-03-31 | 133,577,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2015-01-01 to 2015-03-31 | −$304.9m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months2015-01-01 to 2015-03-31 | $36.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2015-01-01 to 2015-03-31 | $20.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2015-03-31 | $105.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-03-31 | $3.33bn | us-gaap:AssetsCurrent |
| Total assets | At period end2015-03-31 | $5.31bn | us-gaap:Assets |
| Current liabilities | At period end2015-03-31 | $2.02bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2015-03-31 | $1.15bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2015-03-31 | $1.7m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2015-03-31 | $905.6m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2015-03-31 | $1.43bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2015-03-31 | 133,534,165 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000037785-15-000032. Last ingested by Listed: Nov 13, 2026, 16:31 ET. Listed shows no prices and gives no investment advice.